![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Amend Surgical Nabs FDA Clearance for NanoFUSE BA
Amend Surgical Nabs FDA Clearance for NanoFUSE BA
March 2, 2017
The company has received marketing clearance for NanoFUSE BA as a bone graft extender for spine and orthopedic applications.
The device has bioactive glass which facilitates operative site graft containment through rapid bone bonding and the subsequent activation of cellular bone formation. — Cynthia Jessup
Upcoming Events
-
21Oct